Semus Wealth Partners’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$6.18M Buy
5,155
+500
+11% +$511K 2.99% 7
2026
Q1
$4.28M Buy
4,655
+229
+5% +$232K 2.39% 12
2025
Q4
$4.76M Buy
4,426
+32
+0.7% +$30.6K 2.56% 9
2025
Q3
$3.35M Buy
4,394
+391
+10% +$291K 1.9% 16
2025
Q2
$3.12M Buy
4,003
+332
+9% +$258K 2.02% 13
2025
Q1
$3.03M Buy
3,671
+338
+10% +$281K 2.11% 12
2024
Q4
$2.57M Buy
3,333
+232
+7% +$192K 1.7% 13
2024
Q3
$2.75M Buy
3,101
+664
+27% +$597K 1.92% 13
2024
Q2
$2.21M Buy
2,437
+327
+15% +$262K 1.7% 13
2024
Q1
$1.64M Buy
2,110
+134
+7% +$95.4K 1.38% 15
2023
Q4
$1.15M Buy
1,976
+231
+13% +$135K 0.94% 21
2023
Q3
$938K Buy
1,745
+25
+1% +$12.9K 0.87% 24
2023
Q2
$807K Buy
1,720
+126
+8% +$52.8K 0.74% 30
2023
Q1
$547K Buy
1,594
+134
+9% +$45.2K 0.59% 42
2022
Q4
$534K Buy
+1,460
New +$518K 0.65% 41

Other funds holding LLY

Semus Wealth Partners's LLY Position: Q2 2026 in Review

Semus Wealth Partners increased its Eli Lilly (LLY) stake by 11% in Q2 2026, buying an estimated $511K and bringing the position to 5,155 shares worth $6.18M. The position accounts for 2.99% of the portfolio, ranked #7.

Semus Wealth Partners first reported a position in LLY in Q4 2022 and has held it in 15 quarters since. 4,642 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Semus Wealth Partners held 5,155 shares of Eli Lilly worth $6.18M as of Q2 2026.
  • Semus Wealth Partners bought 500 Eli Lilly shares in Q2 2026, an estimated $511K.
  • Eli Lilly made up 2.99% of Semus Wealth Partners's portfolio in Q2 2026, its #7 holding.
  • Semus Wealth Partners first reported a position in Eli Lilly in Q4 2022 and has held it in 15 quarters since.
  • 4,642 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Semus Wealth Partners's 13F filing for Q2 2026, filed 10 Aug 2026.